Skip to main content
Top
Published in: Respiratory Research 1/2010

Open Access 01-12-2010 | Research

Are exhaled nitric oxide measurements using the portable NIOX MINO repeatable?

Authors: Anna Selby, Bernie Clayton, Jane Grundy, Katy Pike, Kirsty Drew, Abid Raza, Ramesh Kurukulaaratchy, S Hasan Arshad, Graham Roberts

Published in: Respiratory Research | Issue 1/2010

Login to get access

Abstract

Background

Exhaled nitric oxide is a non-invasive marker of airway inflammation and a portable analyser, the NIOX MINO (Aerocrine AB, Solna, Sweden), is now available. This study aimed to assess the reproducibility of the NIOX MINO measurements across age, sex and lung function for both absolute and categorical exhaled nitric oxide values in two distinct groups of children and teenagers.

Methods

Paired exhaled nitric oxide readings were obtained from 494 teenagers, aged 16-18 years, enrolled in an unselected birth cohort and 65 young people, aged 6-17 years, with asthma enrolled in an interventional asthma management study.

Results

The birth cohort participants showed a high degree of variability between first and second exhaled nitric oxide readings (mean intra-participant difference 1.37 ppb, 95% limits of agreement -7.61 to 10.34 ppb), although there was very close agreement when values were categorised as low, normal, intermediate or high (kappa = 0.907, p < 0.001). Similar findings were seen in subgroup analyses by sex, lung function and asthma status. Similar findings were seen in the interventional study participants.

Conclusions

The reproducibility of exhaled nitric oxide is poor for absolute values but acceptable when values are categorised as low, normal, intermediate or high in children and teenagers. One measurement is therefore sufficient when using categorical exhaled nitric oxide values to direct asthma management but a mean of at least two measurements is required for absolute values.
Literature
1.
go back to reference GINA: Global Strategy for Asthma Management and Prevention. 2004. GINA: Global Strategy for Asthma Management and Prevention. 2004.
3.
go back to reference The International Study of Asthma and Allergies in Childhood (ISAAC) steering committee: Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Resp J 1998, 12:315–35.CrossRef The International Study of Asthma and Allergies in Childhood (ISAAC) steering committee: Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Resp J 1998, 12:315–35.CrossRef
4.
go back to reference American Thoracic Society, European Respiratory Society: ATS/ERS Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Resp Crit Care Med 2005, 171:912–30.CrossRef American Thoracic Society, European Respiratory Society: ATS/ERS Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Resp Crit Care Med 2005, 171:912–30.CrossRef
5.
go back to reference Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ: Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998, 53:91–5.CrossRefPubMedPubMedCentral Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ: Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998, 53:91–5.CrossRefPubMedPubMedCentral
6.
go back to reference Payne D, Adcock I, Wilson N, Oates T, Scallan M, Bush A: Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001, 164:1376–81.CrossRefPubMed Payne D, Adcock I, Wilson N, Oates T, Scallan M, Bush A: Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001, 164:1376–81.CrossRefPubMed
7.
go back to reference Roberts G, Hurley C, Bush A, Lack G: Longitudinal study of grass pollen exposure, seasonal allergic asthma symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma. Thorax 2004, 59:752–6.CrossRefPubMedPubMedCentral Roberts G, Hurley C, Bush A, Lack G: Longitudinal study of grass pollen exposure, seasonal allergic asthma symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma. Thorax 2004, 59:752–6.CrossRefPubMedPubMedCentral
8.
go back to reference Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR: The Predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001, 164:738–43.CrossRefPubMed Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR: The Predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001, 164:738–43.CrossRefPubMed
9.
go back to reference Jones SL, Herbison P, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR: Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002, 20:601–8.CrossRefPubMed Jones SL, Herbison P, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR: Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002, 20:601–8.CrossRefPubMed
10.
go back to reference Montuschi P, Mondino C, Koch P, Ciabattoni G, Barnes PJ, Baviera G: Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Chest 2007, 132:1876–81.CrossRefPubMed Montuschi P, Mondino C, Koch P, Ciabattoni G, Barnes PJ, Baviera G: Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Chest 2007, 132:1876–81.CrossRefPubMed
11.
go back to reference Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A: Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005, 171:1077–1082.CrossRefPubMed Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A: Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005, 171:1077–1082.CrossRefPubMed
12.
go back to reference Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu AH, Wildfire JJ, Curry MD, Busse WW: Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Am J Resp Crit Care Medicine 2008, 372:1065–1072. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu AH, Wildfire JJ, Curry MD, Busse WW: Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Am J Resp Crit Care Medicine 2008, 372:1065–1072.
13.
go back to reference Jongste JC, Carraro S, Hop WC, CHARISM Study Group, Baraldi E: Daily Telemonitoring of Exhaled Nitric Oxide and Symptoms in the Treatment of Childhood Asthma. Am J Respir Crit Care Med 2009, 179:93–97.CrossRefPubMed Jongste JC, Carraro S, Hop WC, CHARISM Study Group, Baraldi E: Daily Telemonitoring of Exhaled Nitric Oxide and Symptoms in the Treatment of Childhood Asthma. Am J Respir Crit Care Med 2009, 179:93–97.CrossRefPubMed
14.
go back to reference Asthma UK. Where do We Stand?Asthma in the UK Today 2004. Asthma UK. Where do We Stand?Asthma in the UK Today 2004.
15.
go back to reference Alving K, Janson C, Nordvall L: Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res 2006, 7:67.CrossRefPubMedPubMedCentral Alving K, Janson C, Nordvall L: Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res 2006, 7:67.CrossRefPubMedPubMedCentral
16.
go back to reference Khalili B, Boggs PB, L BS: Reliability of a new hand-held device for the measurement of exhaled nitric oxide. Allergy 2007, 62:1171–4.CrossRefPubMed Khalili B, Boggs PB, L BS: Reliability of a new hand-held device for the measurement of exhaled nitric oxide. Allergy 2007, 62:1171–4.CrossRefPubMed
17.
go back to reference Menzies D, Nair A, Lipworth BJ: Portable exhaled nitric oxide measurement: comparison with the "gold standard" technique. Chest 2007, 131:410–4.CrossRefPubMed Menzies D, Nair A, Lipworth BJ: Portable exhaled nitric oxide measurement: comparison with the "gold standard" technique. Chest 2007, 131:410–4.CrossRefPubMed
18.
go back to reference McGill C, Malik G, Turner SW: Validation of a hand-held exhaled nitric oxide analyzer for use in children. Pediatr Pulmonol 2006, 41:1053–7.CrossRefPubMed McGill C, Malik G, Turner SW: Validation of a hand-held exhaled nitric oxide analyzer for use in children. Pediatr Pulmonol 2006, 41:1053–7.CrossRefPubMed
21.
go back to reference Gill M, Graff GR, Adler AJ, Dweik RA: Validation study of fractional exhaled nitric oxide measurements using a handheld monitoring device. J Asthma 2006, 43:731–4.CrossRefPubMed Gill M, Graff GR, Adler AJ, Dweik RA: Validation study of fractional exhaled nitric oxide measurements using a handheld monitoring device. J Asthma 2006, 43:731–4.CrossRefPubMed
22.
go back to reference Tamasi L, Bohacs A, Bikov A, Andorka C, Rigo J, Losonczy G, Horvath I: Exhaled Nitric Oxide in Pregnant Healthy and Asthmatic Women. Journal of Asthma 2009, 46:786–791.CrossRefPubMed Tamasi L, Bohacs A, Bikov A, Andorka C, Rigo J, Losonczy G, Horvath I: Exhaled Nitric Oxide in Pregnant Healthy and Asthmatic Women. Journal of Asthma 2009, 46:786–791.CrossRefPubMed
23.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Resp J 2005, 26:319–38.CrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Resp J 2005, 26:319–38.CrossRef
24.
go back to reference Dreborg S: Skin tests for the diagnosis of IgE-mediated allergy. Allergy 1989,144(supple 10):31–37. Dreborg S: Skin tests for the diagnosis of IgE-mediated allergy. Allergy 1989,144(supple 10):31–37.
26.
go back to reference Gill M, Walker S, Khan A, Green SM, Kim L, Gray S, Krauss B: Exhaled nitric oxide levels during acute asthma exacerbation. Acad Emerg Med 2005, 12:579–86.CrossRefPubMed Gill M, Walker S, Khan A, Green SM, Kim L, Gray S, Krauss B: Exhaled nitric oxide levels during acute asthma exacerbation. Acad Emerg Med 2005, 12:579–86.CrossRefPubMed
27.
go back to reference Taylor DR, Pijnenburg MW, Smith AD, de Jongste JC: Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006, 61:817–827.CrossRefPubMedPubMedCentral Taylor DR, Pijnenburg MW, Smith AD, de Jongste JC: Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006, 61:817–827.CrossRefPubMedPubMedCentral
28.
go back to reference Schneider A, Tilemann L, Schermer T, Gindner L, Laux G, Szecsenyi J, Meyer FJ: Diagnosing Asthma in General Practice with Portable Exhaled Nitric Oxide Measurement - Results of a Prospective Diagnostic Study: FENO ≤ 16 ppb better than FENO ≤ 12 ppb to rule out mild and moderate to severe asthma. Respiratory Research 2009, 10:64.CrossRefPubMedCentral Schneider A, Tilemann L, Schermer T, Gindner L, Laux G, Szecsenyi J, Meyer FJ: Diagnosing Asthma in General Practice with Portable Exhaled Nitric Oxide Measurement - Results of a Prospective Diagnostic Study: FENO ≤ 16 ppb better than FENO ≤ 12 ppb to rule out mild and moderate to severe asthma. Respiratory Research 2009, 10:64.CrossRefPubMedCentral
Metadata
Title
Are exhaled nitric oxide measurements using the portable NIOX MINO repeatable?
Authors
Anna Selby
Bernie Clayton
Jane Grundy
Katy Pike
Kirsty Drew
Abid Raza
Ramesh Kurukulaaratchy
S Hasan Arshad
Graham Roberts
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2010
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-11-43

Other articles of this Issue 1/2010

Respiratory Research 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.